Trends in Scottish newborn screening programme for congenital hypothyroidism 1980-2014: strategies for reducing age

Chourouk Mansour1, Yasmine Ouarezki2, Jeremy Jones3

  • 1Hôpital Universitaire d'Enfants Abderrahim Harouchi, Casablanca, Morocco.

Insights

Scottish newborn screening for congenital hypothyroidism meets most standards, with improvements in timely sampling and notification. However, reducing notification delays after second sampling is crucial for better infant outcomes.

Area of Science:

  • Neonatal screening
  • Endocrinology
  • Public health

Background:

  • Congenital hypothyroidism (CH) requires early detection and treatment to prevent developmental issues.
  • Newborn screening programs aim to identify CH through elevated thyroid-stimulating hormone (TSH) levels.
  • The Scottish program monitors screening and notification timelines to ensure timely intervention.

Purpose of the Study:

  • To evaluate the timeliness of capillary sampling and notification in Scottish newborns with elevated TSH.
  • To assess trends in these timings over a 35-year period (1980-2014).
  • To identify areas for improvement in the screening process, particularly for infants requiring repeat sampling.

Main Methods:

  • Analysis of referral data for newborns screened between 1980 and 2014.
  • Grouping data into seven 5-year blocks for trend analysis.
  • Comparison of median ages at first sampling, notification, and notification after second sampling against established standards.

Main Results:

  • Median age at first capillary sampling decreased from 7 to 5 days between 1980-2014.
  • Median age at notification remained consistently under 14 days, with decreasing ranges over time.
  • A notable proportion of infants (14.6%) had notification delays exceeding 26 days after second sampling, particularly from 2000 onwards.

Conclusions:

  • The Scottish newborn thyroid screening program largely adheres to established standards.
  • There is a need to optimize the notification process, especially for infants requiring repeat testing.
  • Strategies such as timely capillary sampling, rapid laboratory reporting, and electronic communication are recommended to enhance screening efficiency.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.4K